Skip to main content
Download PDF

The Effects of Granulocyte Colony-Stimulating Factor (G-CSF) in Pre-Clinical Models of Infection and Acute Inflammation

Sepsis volume 2, pages 213–220 (1998)Cite this article

References

  1. Abraham E, Stevens P. Effects of granulocyte colony stimulating factor in modifying mortality from Pseudomonas aeruginosa pneumonia after hemorrhage. Crit Care Med 1992;20:1127-1133.

    PubMed  Google Scholar 

  2. Anderlini P, Przepiorka D, Champlin R, Körbling M. Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals. Blood 1996;88:2819-2825.

    PubMed  Google Scholar 

  3. Avalos BR. Molecular analysis of the granulocyte colony-stimulating factor receptor. Blood 1996;88:761-777.

    PubMed  Google Scholar 

  4. Barsig J, Bundschuh DS, Hartung T, Bauhofer A, Sauer A, Wendel A. Control of fecal peritoneal infection in mice by colony-stimulating factors. J Infect Dis 1996;174:790-799.

    PubMed  Google Scholar 

  5. Bradley TR, Metcalf D. The growth of mouse bone marrow cells in vitro. Aust J Exp Biol Med Sci 1966;44:287-294.

    PubMed  Google Scholar 

  6. Buisman AM, Langermans JA, Van Furth R. Effect of granulocyte colony-stimulating factor on the course of infection with Gram positive bacteria in mice during granulocytopenia induced by sublethal irradiation or cyclophosphamide. J Infect Dis 1996;174:417-421.

    PubMed  Google Scholar 

  7. Cairo MS, Plunkett JM, Mauss D, Van de Ven C. Seven-day administration of recombinant human granulocyte colony-stimulating factor to newborn rats: Modulation of neonatal neutrophilia, myelopoiesis, and Group B Streptococcus sepsis. Blood 1990;76:1788-1794.

    PubMed  Google Scholar 

  8. Cebon J, Layton J, Maher D, Morstyn G. Endogenous hematopoietic growth factors in neutropenia and infection. Br J Haematol 1994;86:274.

    Google Scholar 

  9. Dale DC, Liles WC, Summer WR, Nelson S. Review: Granulocyte colony-stimulating factor role and relationships in infectious diseases. J Infect Dis 1995;172:1075.

    Google Scholar 

  10. DeMarsh PL, Sucolski SK, Frey CL, Bhatnagar PK, Koltin Y, Actor P, Petteway SR. Efficacy of the hematoregulatory peptide SK&F 107647 in experimental Candida albicans infections in normal and immunosuppressed mice. Immunopharm. 1994;27:199-206.

    Google Scholar 

  11. Dunne JR, Dunkin BJ, Nelson S, White JC. Effects of granulocyte colony stimulating factor in a nonneutropenic rodent model of Escherichia coli peritonitis. J Surg Res 1996;61:348-354.

    PubMed  Google Scholar 

  12. Eaves-Pyles T, Alexander JW. Granulocyte colony-stimulating factor enhances killing of translocated bacteria but does not affect barrier function in a burn mouse model. J Trauma 1996;41:1013-1017.

    PubMed  Google Scholar 

  13. Eichacker PQ, Waisman Y, Natanson C, Farese A, Hoffman WD, Banks SM, Macvittie TJ. Cardiopulmonary effects of granulocyte colony-stimulating factor in a canine model of bacterial sepsis. J Appl Physiol 1994;77:2366-2373.

    PubMed  Google Scholar 

  14. Fink MP, O'Sullivan BP, Menconi MJ, Wollert SP, Wang H, Youssef ME, Bellelsle JM. Effect of granulocyte colony-stimulating factor on systemic and pulmonary responses to endotoxin in pigs. J Trauma 1993;34:571-578.

    PubMed  Google Scholar 

  15. Freeman BD, Correa R, Karzai W, et al. Controlled trials of rG-CSF and CD11b-directed MAb during hyperoxia and E. coli pneumonia in rats. J Appl Physiol 1996;80:2066-2076.

    PubMed  Google Scholar 

  16. Freeman BD, Quezado Z, Zeni F, et al. rG-CSF reduces endotoxemia and improves survival during E. coli pneumonia. J Appl Physiol 1997;83:1467-1475.

    PubMed  Google Scholar 

  17. Gorgen I, Hartung T, Leist M, et al. Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharde-induced toxicity via suppression of systemic tumor necrosis factor-alpha J Immunol 1992;149:918-924.

    PubMed  Google Scholar 

  18. Goya T, Torisu M, Doi F, Yoshida T. Effects of granulocyte colony-stimulating factor and monobactam antibiotics (Aztreonam) on neutrophil functions in sepsis. Clin Immunol Immunopathol 1993;69:278-284.

    PubMed  Google Scholar 

  19. Graybill JR, Bocanegra R, Luther M. Antifungal combination therapy with granulocyte colony-stimulating factor and fluconazole in experimental disseminated Candidiasis. Eur J Clin Microbiol Infect Dis 1995;14:700-703.

    PubMed  Google Scholar 

  20. Haberstroh J, Breuer H, Lucke l, et al. Effect of recombinant human granulocyte colony-stimulating factor on hemodynamic and cytokine response in a porcine model of Pseudomonas sepsis. Shock 1995;4:216-224.

    PubMed  Google Scholar 

  21. Haberstroh J, Wiese K, Geist A, et al. Effect of delayed treatment with recombinant human granulocyte colony-stimulating factor on survival and plasma cytokine levels in a non-neutropenic porcine model of Pseudomonas aeruginosa sepsis. Shock 1998;9:128-134.

    PubMed  Google Scholar 

  22. Hamood M, Bluche PF, De Vroey C, Corazza F, Bujan W, Fondu P. Effects of recombinant human granulocyte colony-stimulating factor on neutropenic mice infected with Candida albicans: acceleration of recovery from neutropenia and potentiation of anti-C. albicans resistance. Mycoses 1994;37:93-99.

    PubMed  Google Scholar 

  23. Hanaoka M, Kubo K, Miyahara T, Hayano T, Koizumi T, Kobayashi T, Sekiguchi M. Effect of post-treatment with granulocyte colony-stimulating factor on endotoxin-induced lung injury in sheep. Exp Lung Res 1998;24:15-25.

    PubMed  Google Scholar 

  24. Heard SO, Fink MP, Gamelli RL, et al. The Filgrastim Study Group. Effect of prophylactic administration of recombinant human granulocyte colony-stimulating factor (filgrastim) on the frequency of nosocomial infections in patients with acute traumatic brain injury or cerebral hemorrhage. Crit Care Med 1998;26:748-754.

    PubMed  Google Scholar 

  25. Hebert JC, O'Reilly M, Barry B, Shatney L, Sartorelli K. Effects of exogenous cytokines on intravascular clearance of bacteria in normal and splenectomized mice. J Trauma 1997;43:875-879.

    PubMed  Google Scholar 

  26. Held TK, Mielke ME, Chedid M, Unger M, Trautmann M, Huhn D, Cross AS. Granulocyte colony-stimulating factor worsen the outcome of experimental Klebsiella pneumoniae pneumonia through direct interaction with the bacteria. Blood 1998;91:2525-2535.

    PubMed  Google Scholar 

  27. Hustinx W, Benaissa-Trouw B, Van Kessel K, et al. Granulocyte colony-stimulating factor enhances protection by anti-K1 capsular lgM antibody in murine Escherichia coli sepsis. Eur J Clin Invest 1997;27:1044-1048.

    PubMed  Google Scholar 

  28. Ichikawa Y, Pluznik DH, Sachs RJ. In vitro control of the development of macrophage and granulocyte colonies. Proc Natl Acad Sci USA 1966;56:495.

    Google Scholar 

  29. Iguchi K, Inoue S, Kmar A. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats. Exp Hematol 1991;19:352-358.

    PubMed  Google Scholar 

  30. Ishikawa K, Tanaka H, Matsuoka T, Shimazu T, Yoshioka T, Sugimoto H. Recombinant human granulocyte colony-stimulating factor attenuates inflammatory responses in septic patients with neutropenia. J Trauma 1998;44:1047-1054.

    PubMed  Google Scholar 

  31. Kanazawa M, Ishizaka A, Hasegawa N, Suzuki Y, Yokoyama T. Granulocyte colony-stimulating factor does not enhance endotoxin-induced acute lung injury in guinea pigs. Am Rev Respir Dis 1992;145:1030-1035.

    PubMed  Google Scholar 

  32. Kawakami M, Tsutsumi H, Kumakawa T, et al. Levels of serum granulocyte colony-stiulating factor in patients with infections. Blood 1990;78:3254-3258.

    Google Scholar 

  33. Kayashima S, Tsuruu S, Hata N, Rokutanda M. Therapeutic effect of granulocyte colony-stimulating factor (G-CSF) on the protection against Listeria infection in SCID mice. Immunology 1993;80:471-476.

    PubMed  Google Scholar 

  34. King J, Deboisblanc BP, Mason CM, et al. Effect of granulocyte colony-stimulating factor on acute lung injury in the rat. Am J Resp Crit Care Med 1995;151:302-309.

    PubMed  Google Scholar 

  35. Koike K, Moore FA, Moore EE, Poggetti RS, Tuder RM, Banerjee A. Endotoxin after gut ischemia/reperfusion causes irreversible lung injury. J Surg Res 1992;52:656-662.

    PubMed  Google Scholar 

  36. Koizumi T, Kubo K, Shinozaki S, Koyama S, Kobayashi T, Sekiguchi M. Granulocyte colony-stimulating factor does not exacerbate endotoxin-induced lung injury in sheep. Am Rev Respir Dis 1993;148:132-137.

    PubMed  Google Scholar 

  37. Kullberg B-J, Netea MG, Curfs JH, Keuter M, Meis JF, van der Meer JW. Recombinant murine granulocyte colony-stimulating factor protects against acute disseminated Candida albicans infection in nonneutropenic mice. J Infect Dis 1998;177:175-181.

    PubMed  Google Scholar 

  38. Lister PD, Gentry MJ, Preheim LC. Granulocyte colony-stimulating factor protects control rats but not ethanol-fed rats from fatal pneumococcal pneumonia. J Infect Dis 1993;168:922-926.

    PubMed  Google Scholar 

  39. Liu F, Poursine-Laurent J, Link DC. The granulocyte colony-stimulating factor receptor is required for the mobilization of murine hematopoietic progenitors into peripheral blood by cyclophoshamide or interleukin-8 but not flt-3 ligand. Blood 1997;90:2522-2528.

    PubMed  Google Scholar 

  40. Lorenz W, Reimund K-P, Weitzel F, et al. Granulocyte colony-stimulating factor prophylaxis before operation protects against lethal consequences of postoperative peritonitis. Surgery 1994;116:925-934.

    PubMed  Google Scholar 

  41. Lundblad R, Nesland JM, Giercksky KE. Granulocyte colony-stimulating factor improves survival rate and reduces concentrations of bacteria, endotoxin, tumor necrosis factor, aned endothelin-1 in fulminant intra-abdominal sepsis in rats. Crit Care Med 1996;24:820-826.

    PubMed  Google Scholar 

  42. Lundblad R, Wang MY, Kvalheim G, Lingaas E, Giercksky KE. Granulocyte colony-stimulating factor improves myelopoiesis and host defense in fulminant intra-abdominal sepsis in rats. Shock 1995;4:68-73.

    PubMed  Google Scholar 

  43. Matsumoto M, Matsubara S, Yokota T. Effect of combination therapy with recombinant human granulocyte colony-stimulating factor (r G-CSF) and antibiotics in neutropenic mice unresponsive to antibiotics alone. J Antimicrob Chemother 1991;28:447-453.

    PubMed  Google Scholar 

  44. Muranaka H, Suga M, Nakagawa K, Sato K, Gushima Y, Ando M. Effects of granulocyte ad granulocyte-macrophage colony-stimulating factors in a neutropenic murine model of trichosporonosis. Infect Immun 1997;65:3422-3429.

    PubMed  Google Scholar 

  45. Nelson S, Bagby GJ. Granulocyte colony-stimulating factor and modulation of inflammatory cells in sepsis. Clin Chest Med 1996;17:319-332.

    PubMed  Google Scholar 

  46. Nicola NA, Metcalf D, Matsumoto M, Johnson GR. Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. J Biol Chem 1983;258:9017-9023.

    PubMed  Google Scholar 

  47. Novales JS, Salva AM, Modanlou HD, Kaplan DL, del Castillo J, Anderson J, Medlock ES. Maternal administration of granulocyte colony-stimulating factor improves neonatal rat survival after lethal group B Streptococcal infection. Blood 1993;81:923-927.

    PubMed  Google Scholar 

  48. O'Reilly M, Silver GM, Greenhalgh DG, Gamelli RL, Davis JH, Hebert JC. Treatment of intra-abdominal infection with granulocyte colony-stimulating factor. J Trauma 1992;33:679-682.

    PubMed  Google Scholar 

  49. Pajkrt D, Manten A, van der Poll T, et al. Modulation of cytokine release and neutrophil function by granulocyte colony-stimulating factor during endotoxemia in humans. Blood 1997;90:1415-1424.

    PubMed  Google Scholar 

  50. Patton JH Jr, Lyden SP, Rgasdale DN, Croce MA, Fabian TC, Proctor KG. Granulocyte colony-stimulating factor improves host defense to resuscitated shock and polymicrobial sepsis without provoking generalized neutrophil-mediated damage. J Trauma 1998;44:750-758.

    PubMed  Google Scholar 

  51. Piper RD, Cook DJ, Bone RC, Sibbald WJ. Introducing Critical Appraisal to studies of animal models investigating novel therapies in sepsis. Crit Care Med 1996;24:2059-2070.

    PubMed  Google Scholar 

  52. Polak-Wyss A. Protective effect of human granulocyte colony-stimulating factor (h G-CSF) on Candida infections in normal and immunosuppressed mice. Mycoses 1991;34:109-118.

    PubMed  Google Scholar 

  53. Polmächer T, Korth C, Mullington J, et al. Effects of granulocyte colony-stimulating factor on plasma cytokine and cytokine receptor levels and on the in vivo host response to endotoxin in healthy men. Blood 1996;87:900.

    PubMed  Google Scholar 

  54. Preheim LC, Snitily MU, Gentry MJ. Effects of granulocyte colony-stimulating factor in cirrhotic rats with pneumococcal pneumonia. J infect Dis 1996; 174:225-228.

    PubMed  Google Scholar 

  55. Rao R, Prinz RA, Kazantsev GB, et al. Effects of granulocyte colony-stimulating factor in severe pancreatitis. Surgery 1996;119:657-663.

    PubMed  Google Scholar 

  56. Schilero GJ, Oropello J, Benjamin E. Impairment in gas exchange after granulocyte colony stimulating factor (G-CSF) in a patient with the adult respiratory distress syndrome. Chest 1995;107:276-278.

    PubMed  Google Scholar 

  57. Serushago BA, Yoshikai Y, Handa T, Mitsuyama M, Muramori K, Nomoto K. Effect of recombinant human granulocyte colony-stimulating factor (rh G-CSF) on murine resistance against Listeria monocytogenes. Immunology 1992;75:475-480.

    PubMed  Google Scholar 

  58. Seymour JF, Lieschke GJ, Grail D, Quillici C, Hodgson G, Dunn AR. Mice lacking both granulocyte colony-stimulating factor (CSF) and granulocyte macrophage CSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and redced long term survival. Blood 1997;90:3037-3049.

    PubMed  Google Scholar 

  59. Shinomiya N, Tsuru S, Katsura Y, Kayashima S, Nomoto K. Enhanced resistance against Listeria monocytogenes achieved by pretreatment with granulocyte colony-stimulating factor. Infect Immun 1991;59:4740-4743.

    PubMed  Google Scholar 

  60. Shirai R, Kadoto T, Tomono K, Ogawa K, lida K, Kawakami K, Kohno S. Protective effect of granulocyte colony-stimulating factor (G-CSF) in a granulocytopenic mouse model of Pseudomonas aeruginosa lung infection through enhanced phagocytosis and killing by alveolar macrophages through priming tumor necrosis factor α (TNF-α) production. Clin exp Immunol 1997;109:73-79.

    PubMed  Google Scholar 

  61. Smith WS, Sumnicht GE, Sharpe RW, Samuelson D, Millard FE. Granulocyte colony-stimulating factor versus placebo in addition to penicillin G in a randomized blinded study of gram-negative pneumonia sepsis: Analysis of survival and multisystem organ failure. Blood 1995;86:1301-1309.

    PubMed  Google Scholar 

  62. Steinshamn S, Bergh K, Waage A. Effects of stem cell factor and granulocyte colony-stimulating factor on granulocyte recovery and Candida albicans infection in granulocytopenic mice. J Infect Dis 1993;168:1444-1448.

    PubMed  Google Scholar 

  63. Terashima T, Kanazawa M, Sayama K, et al. Granulocyte colony-stimulating factor exacerbates acute lung injury induced by intratracheal endotoxin in guinea pigs. Am J Resp Crit Care Med 1994;149:1295-1303.

    PubMed  Google Scholar 

  64. Tian S-S, Lamb P, King AG, et al. A small, nonpeptidyl mimic of granulocyte colony-stimulating factor. Science 1998;281:257-259.

    PubMed  Google Scholar 

  65. Toda H, Murata A, Matsuura N, Uda K, Oka Y, Tanaka N, Mori T. Therapeutic efficacy of granulocyte colony stimulating factor against rat cecal ligation and puncture model. Stem Cells 1993;11:228-234.

    PubMed  Google Scholar 

  66. Uchida K, Yamamoto Y, Klein TW, Friedman H, Yamaguchi H. Granulocyte colony-stimulating factor facilities the restoration of residence to opportunistic fungi in leukopenic mice. J Med Vet Mycol 1992;30:293-300.

    PubMed  Google Scholar 

  67. Vollmar B, Messner S, Wanner GA, Hartung T, Menger MD. Immunomodulatory ation of G-CSF in a rat model of endotoxin-induced liver injury: An intravital microscopic analysis of Kupffer cell and leukocyte response. J Leuk Biol 1997;62:710-718.

    Google Scholar 

  68. Wakiyama H, Tsuru S, Hata N, et al. Therapeutic effect of granulocyte colony-stimulating factor and cephem antibiotics against experimental infections in neutropenic mice induced by cyclophosphamide. Clin Exp Immunol 1993;92:218-224.

    PubMed  Google Scholar 

  69. Zhang P, Bagby GJ, Stoltz DA, Spitzer JA, Summer WR, Nelson S. Modulation of the lung host response by granulocyte colony-stimulating factor in rats challenged with intrapulmonary endotoxin. Shock 1997;7:193-199.

    PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Surgery and the Critical Care Medicine Programme, the Toronto Hospital, University of Toronto, Canada

    John C. Marshall

Authors
  1. John C. Marshall
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Marshall, J.C. The Effects of Granulocyte Colony-Stimulating Factor (G-CSF) in Pre-Clinical Models of Infection and Acute Inflammation. Sepsis 2, 213–220 (1998). https://doi.org/10.1023/A:1009829712638

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009829712638

Keywords

  • Public Health
  • Emergency Medicine
  • Acute Inflammation